Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Predicting Molecular Geometry02:27

Predicting Molecular Geometry

43.9K
VSEPR Theory for Determination of Electron Pair Geometries
43.9K
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving01:29

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving

226
Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
226
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

203
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
203
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

163
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
163
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

1.0K
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
1.0K
Molecular Models02:00

Molecular Models

43.2K
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
43.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FLOWR.ROOT - A flow matching-based foundation model for joint multi-purpose structure-aware 3D ligand generation and affinity prediction.

Nature communications·2026
Same author

Scalable Boltzmann generators for equilibrium sampling of large-scale materials.

Nature communications·2026
Same author

FLOWR: flow matching for structure-aware de novo, interaction- and fragment-based ligand generation.

Nature computational science·2026
Same author

Iminopyridonato Iridium Complexes: <i>O</i>-Functionalization via C-X Bond Cleavage.

Inorganic chemistry·2026
Same author

Assessing generative modeling approaches for free energy estimates in condensed matter.

The Journal of chemical physics·2026
Same author

Circularly Polarized Luminescent and Melt-Processable Copper(I)-Organic Glasses Based on 2,2'-Bis(diphenylphosphino)-1,1'-binaphthyl.

Angewandte Chemie (International ed. in English)·2026

Related Experiment Video

Updated: Dec 22, 2025

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.5K

grünifai: interactive multiparameter optimization of molecules in a continuous vector space.

Robin Winter1,2, Joren Retel1, Frank Noé2

  • 1Department of Digital Technologies, Bayer AG, Berlin 13353, Germany.

Bioinformatics (Oxford, England)
|May 6, 2020
PubMed
Summary

We developed grünifai, an interactive platform for in silico drug discovery. It aids in optimizing small molecules by balancing multiple properties for next-generation compounds.

More Related Videos

Author Spotlight: In Silico Creation and Impact of Carbonylated Amino Acids on Protein Structure and Function
05:57

Author Spotlight: In Silico Creation and Impact of Carbonylated Amino Acids on Protein Structure and Function

Published on: April 26, 2024

753
Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs
05:00

Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs

Published on: August 9, 2024

1.8K

Related Experiment Videos

Last Updated: Dec 22, 2025

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.5K
Author Spotlight: In Silico Creation and Impact of Carbonylated Amino Acids on Protein Structure and Function
05:57

Author Spotlight: In Silico Creation and Impact of Carbonylated Amino Acids on Protein Structure and Function

Published on: April 26, 2024

753
Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs
05:00

Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs

Published on: August 9, 2024

1.8K

Area of Science:

  • Medicinal Chemistry
  • Computational Chemistry
  • Drug Discovery

Background:

  • Optimizing small molecules in drug discovery is challenging due to the need to balance multiple molecular properties simultaneously.
  • Existing computational tools may not adequately support multiparameter optimization with interactive steering.

Purpose of the Study:

  • To introduce grünifai, a novel interactive in silico platform for compound optimization.
  • To support the design of next-generation drug candidates under multiparameter constraints.

Main Methods:

  • Development of an interactive in silico compound optimization platform (grünifai).
  • Integration of adjustable in silico models and a continuous chemical space representation.
  • Implementation of a scalable particle swarm optimization algorithm with user feedback capabilities.

Main Results:

  • grünifai facilitates the ideation of novel compounds by addressing multiparameter optimization challenges.
  • The platform allows active steering of compound optimization through user feedback on generated structures.
  • Open-source availability of the platform's code and documentation.

Conclusions:

  • grünifai offers a powerful interactive solution for complex small molecule optimization in drug discovery.
  • The platform's design supports efficient exploration of chemical space for improved drug candidates.
  • The open-source nature promotes accessibility and further development in computational drug design.